ORAL VACCINE AGAINST RUMINANT RESPIRATORY DISEASE COMPRISING POLYVINYLPYRROLIDONE

The present invention relates to an oral vaccine against respiratory disease in ruminants, comprising live attenuated Mannheimia haemolytica bacteria and a Polyvinylpyrrolidone (PVP). The addition of PVP significantly improves the protective effect of vaccination on lung scores after a challenge inf...

Full description

Saved in:
Bibliographic Details
Main Authors EDDY, BRAD, O'CONNELL, KEVIN, VAIDYANATHAN, SUBRAMANIAM
Format Patent
LanguageEnglish
French
Published 21.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to an oral vaccine against respiratory disease in ruminants, comprising live attenuated Mannheimia haemolytica bacteria and a Polyvinylpyrrolidone (PVP). The addition of PVP significantly improves the protective effect of vaccination on lung scores after a challenge infection. Further the PVP allows vaccination by a method of mass administration, such as by oral route via a drink. In addition the invention relates to methods for the preparation of such a vaccine, to methods for the vaccination of ruminants employing such a vaccine, and to medical uses of a composition comprising M. haemolytica bacteria. La présente invention concerne un vaccin oral contre les maladies respiratoires chez les ruminants, comprenant des bactéries Mannheimia haemolytica atténuées vivantes et une Polyvinylpyrrolidone (PVP). L'ajout de PVP améliore significativement l'effet protecteur de la vaccination sur les scores pulmonaires après une épreuve d'infection. En outre, la PVP permet la vaccination par un procédé d'administration de masse, par exemple par voie orale, via une boisson. De plus, l'invention concerne des procédés pour la préparation d'un tel vaccin, des procédés pour la vaccination de ruminants employant un tel vaccin, et des utilisations médicales d'une composition comprenant bactéries M. haemolytica.
Bibliography:Application Number: CA20173044335